Applied Biosystems TrueMark PGx SNP + CNV Real-Time PCR Solution Introduced
Thermo Fisher Scientific has launched the Applied Biosystems TrueMark PGx SNP + CNV Real-Time PCR Solution.
Category: Molecular Diagnostics
Molecular Diagnostics
Latest
Molecular Diagnostics
Latest
SeqStudio Flex Dx Launched by Thermo Fisher Scientific
Thermo Fisher Scientific introduces the SeqStudio Flex Dx Genetic Analyzer, an IVDR-compliant capillary electrophoresis system.
Molecular Diagnostics
Latest
New England Biolabs Presents Latest Innovations in NGS
New England Biolabs showcased advanced sample preparation technologies at AGBT, focusing on improved sequencing data quality and efficiency.
Datar Cancer Genetics Unveils Advanced Blood Test for MRD
Datar Cancer Genetics introduced a blood test that combines tumor-agnostic NGS and tumor-informed dd-PCR to detect MRD.
Read More
FDA Grants Breakthrough Device Designation for CRISPR Blood Test for Tuberculosis
IntelliGenome’s CRISPR-TB Blood Test, designed to detect Mycobacterium tuberculosis cfDNA, received FDA Breakthrough Device Designation.
Read More
How Long-Read Sequencing Could Revolutionize Rare Genetic Disease Diagnosis
Researchers demonstrate the potential of long-read sequencing to diagnose rare genetic diseases faster and more accurately.
Read More
Blood Biomarkers Linked to SIDS Risk Identified
Researchers identified blood biomarkers associated with Sudden Infant Death Syndrome, paving the way for diagnostic tests for infants.
Read More
OGT Launches Myeloid MRD Panel for Sensitive AML Biomarker Detection
OGT’s SureSeq Myeloid MRD Panel offers a NGS solution for ultra-sensitive detection of MRD biomarkers in acute myeloid leukemia.
Read More
Bio-Rad Launches New ddPCR Kits for AAV Serotypes 2 and 8
Bio-Rad Labs expanded its Vericheck ddPCR Empty-Full Capsid Kit for precise measurement of capsid content to support gene therapies.
Read More
Avalon Healthcare Solutions and Sentara Health Plans Partner on Genetic Testing Management
Avalon Healthcare Solutions expanded its partnership with Sentara Health Plans for evidence-based genetic testing management services.
Read More
Using mcfDNA Testing for Pediatric Head and Neck Infection Diagnosis
Researchers demonstrated the potential of mcfDNA testing to identify pathogens in pediatric head and neck infections.
Read More
Scientists Discover Potential Blood Test for Asthma Diagnosis and Severity
Scientists identified a blood marker that can diagnose asthma and assess its severity, potentially transforming asthma diagnosis.
Read More
NCCN Guidelines Add ctDNA-MRD Testing Recommendation for B-Cell Lymphoma
Foresight Diagnostics’ ctDNA-MRD testing has been included in the NCCN Clinical Practice Guidelines for diffuse large B-cell lymphoma.
Read More
Tempus Unveils New Whole-Genome Sequencing Assay
The whole-genome sequencing assay enhances precision medicine by identifying relevant genetic alterations in hematological malignancies.
Read More
Risk of Lung Cancer Recurrence Linked to ctDNA Levels
A new demonstrates the high sensitivity of the NeXT Personal test for detecting ctDNA in early-stage lung cancer.
Read More
Genetic Test for Opioid Use Disorder Risk Faces Accuracy Concerns
A study found that an FDA-approved genetic test for opioid use disorder risk may produce high rates of false positives and false negatives.
Read More
Advancing BRCA2 Variant Classification to Enhance Hereditary Cancer Care
Summary: A Mayo Clinic-led international study utilized CRISPR-Cas9 technology to classify 91% of...
Read More
MD Anderson and Myriad Genetics Partner on MRD Assay Development
Myriad Genetics and MD Anderson Cancer Center are partnering to advance the development of a molecular residual disease (MRD) assay.
Read More